Treatment with ginsenoside Rg1 has shown a notable impact on breast cancer tissues by downregulating SNAIL2 expression and significantly attenuating the expression of pivotal regulators of cell growth, including MAPK, EGFR, and TGF-β(Chu et al., 2020). Here, EGFR is linked to breast cancer.